Overview  >  Investor Relations  >  Events & Presentations  >  Event Details

Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate